Rivista di formazione e aggiornamento di pediatri e medici operanti sul territorio e in ospedale. Fondata nel 1982, in collaborazione con l'Associazione Culturale Pediatri
Gli articoli più visti nel mese di Luglio 2025
1) La pagina gialla - Giugno 2025
a cura di Sara Lega
70 kB
4) Farmacoriflessioni - Giugno 2025
Trattamento della scabbia
- Sapigni E, Nigro R, Mattei G, Matteo G, Di Nuzzo S, Motolese A, Corazza M, Conti A, Marchetti F.
- Scabies, a parasitic dermatosis caused by Sarcoptes scabiei, is classified by the World Health Organization as a neglected tropical disease due to its global burden. In recent years, the Emilia-Romagna Region has reported a significant increase in scabies cases, with higher incidence among males, children, adolescents and young adults. This guideline aims to provide evidence-based recommendations for the diagnosis, treatment and management of scabies, by focusing on target populations and types of scabies, with specific consideration for paediatric patients. The guideline was developed by a multidisciplinary team of dermatologists, paediatricians, public health officials and pharmacists from the Emilia-Romagna Region. It is based on systematic reviews, meta-analyses and international guidelines published in the last six years (2019-2024). Permethrin 5% topical cream remains the first-line therapy. Benzyl benzoate and oral ivermectin are effective alternatives in selected cases; oral ivermectin is specifically recommended for treating large groups or patients with extensive eczema. Crusted scabies requires a combination of topical and systemic agents, along with keratolytics. Early treatment of close contacts and a structured two-week follow-up are also recommended. A practical section on paediatric topical application is included to assist caregivers and improve compliance. This guideline supports healthcare professionals in the standardised management of scabies and emphasizes the need for effective interventions to address the rising incidence of cases.
5) Casi indimenticabili - Giugno 2025
MPAM (Mycoplasma Pneumoniae Associated Mucositis): chi è costei?
- Zannoni S, Iacono A, Radice C, Addeo AM, Marchetti F.
- The paper reports the case of an 11-year-old boy with aphthous lesions in the oral cavity caused by a Mycoplasma pneumoniae infection, which may present with severe mucositis, mimicking more serious conditions such as Stevens-Johnson syndrome.
5) Casi indimenticabili - Giugno 2025
Aftosi orale e bruxismo
- Somma CE, Alfaro C, Acampora E.
- A 26-month-old girl presented with episodes of oral aphthosis associated with frequent night-time awakenings and sudden, intense crying. After having ruled out organic causes, she was sent to a neuropsychiatric evaluation that led to a diagnosis of a sleep disorder associated with nocturnal bruxism, causing recurrent trauma to the oral cavity and the appearance of mouth ulcers.
5) Casi indimenticabili - Giugno 2025
Una micobatteriosi non così tanto “atipica”
- Sfeir R.
- In the presence of unilateral lymph node swelling that has persisted for more than 3 weeks, in the absence of suspicious signs of malignancy, unresponsive to first-line antibiotic therapy, it is appropriate to consider a non-tuberculous mycobacterial infection in the differential diagnosis.
5) Casi indimenticabili - Giugno 2025
Sapere riconoscere l’epilessia mioclonica giovanile
- Rossetti V.
- A 15-year-old girl experienced episodes characterised by blurred vision accompanied by limb spasms, during which she would drop objects from her hands and, on some occasions, fall to the ground while remaining conscious. Initially interpreted as manifestations of the anxiety she frequently suffered from, these episodes were later identified as symptoms of juvenile myoclonic epilepsy.
6) Rubrica iconografica - Giugno 2025
Quando il contesto familiare dice già tutto: la scabbia
- Nicolardi F, Calligaris L, Berti I.
7) Aggiornamento - Giugno 2025
I disturbi respiratori ostruttivi del sonno
- Basilicata S, Traunero A, Borrelli M, Maschio M, Ghirardo S, Amaddeo A.
- Obstructive sleep disordered breathing encompasses different clinical entities, the most severe of which is obstructive sleep apnea syndrome (OSAS). Children with severe adenotonsillar hypertrophy, obesity, congenital malformations or specific syndromes are most likely to develop OSAS. Even though the diagnostic gold standard is polysomnography (PSG), alternative diagnostic tools are currently more used and seem to be more cost-effective and less time-consuming for families and sleep technicians. Therapeutic approach may be pharmaceutical, surgical or, in more severe cases, needs ventilation therapy.